3-46373394-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001394783.1(CCR5):āc.492C>Gā(p.Ile164Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,612,246 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_001394783.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCR5 | NM_001394783.1 | c.492C>G | p.Ile164Met | missense_variant | 2/2 | ENST00000292303.5 | NP_001381712.1 | |
CCR5AS | NR_125406.1 | n.392-1977G>C | intron_variant, non_coding_transcript_variant | |||||
CCR5 | NM_000579.4 | c.492C>G | p.Ile164Met | missense_variant | 3/3 | NP_000570.1 | ||
CCR5 | NM_001100168.2 | c.492C>G | p.Ile164Met | missense_variant | 3/3 | NP_001093638.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCR5 | ENST00000292303.5 | c.492C>G | p.Ile164Met | missense_variant | 2/2 | 1 | NM_001394783.1 | ENSP00000292303 | P1 | |
CCR5AS | ENST00000701879.1 | n.174-1977G>C | intron_variant, non_coding_transcript_variant | |||||||
CCR5 | ENST00000445772.1 | c.492C>G | p.Ile164Met | missense_variant | 1/1 | ENSP00000404881 | P1 | |||
CCR5AS | ENST00000451485.2 | n.392-1977G>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000396 AC: 6AN: 151630Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251256Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135798
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1460616Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 726618
GnomAD4 genome AF: 0.0000396 AC: 6AN: 151630Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 4AN XY: 74042
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The CCR5 p.Ile164Met variant was identified in the literature however the frequency of this variant in an affected population was not provided. The variant was also identified in dbSNP (ID: rs1800942) and LOVD 3.0 (Effect on protein unknown). The variant was not identified in ClinVar or Cosmic. The variant was identified in control databases in 9 of 251256 chromosomes at a frequency of 0.000036 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 8 of 113576 chromosomes (freq: 0.00007) and Latino in 1 of 34586 chromosomes (freq: 0.000029); it was not observed in the African, Ashkenazi Jewish, East Asian, European (Finnish), Other, and South Asian populations. In an in vitro study, it was found that the variant may be capable of disrupting ribosomal frameshifting activity (Belew_2014_PMID: 25043019). The p.Ile164 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at